# Valneva

> Specialty vaccine development and commercialization

Business model and tags: B2B, B2G, Has physical offices, Publicly traded, Manufacturing, Multi-product, Sales-led purchase, Pharma & life sciences, Multi-site, International operations, Has production sites, Has in-house R&D, Has a works council

## About Valneva

Specialty vaccine company developing prophylactic vaccines for infectious diseases, including travel vaccines and candidates for Lyme disease, Zika virus, and more

## Key facts

- **Industry**: Biotechnology Research
- **Company size**: 251–1,000 employees
- **Headquarters**: Saint-Herblain, Pays de la Loire, France
- **Founded**: 2013
- **Revenue**: €175M (FY2025, publicly reported)
- **SIREN**: [422497560](https://annuaire-entreprises.data.gouv.fr/entreprise/422497560)
- **Website**: [valneva.com](https://valneva.com/)
- **LinkedIn**: [linkedin.com/company/valneva](https://www.linkedin.com/company/valneva)

## Valneva account plan

Valneva is a Lyon-based specialty vaccine company with three travel vaccines, FY2025 revenues of €174.7 million and a Lyme vaccine partnered with Pfizer.

[Read the Valneva account plan](https://www.tamtam.ai/c/valneva/account-plan)

## Valneva in the news

- [L'action Valneva en queue du SBF 120, -18,5 % sur trois mois](https://www.ideal-investisseur.fr/actions-b/laction-valneva-en-queue-du-sbf-120-185-sur-trois-mois/29620.html) · ideal-investisseur.fr · Nov 18, 2026
  Valneva's stock is down by 1.92% to 2.50 , marking an 18.55% loss over three months, ahead of its nine-month results release on November 24th.
- [Valneva shares fall 15% over three months and drop back below their MM50](https://www.ideal-investisseur.fr/en/stock-news/valneva-shares-fall-15-over-three-months-and-drop-back-below-their-mm50/29548.html) · ideal-investisseur.fr · Nov 17, 2026
  Valneva's stock price fell 2.15% to 2.55 euros, dropping below its 50-day moving average and showing a 15.13% decline over three months.
- [L'action Valneva lâche 15 % sur trois mois et repasse sous sa MM50](https://www.ideal-investisseur.fr/actions-b/laction-valneva-lache-15-sur-trois-mois-et-repasse-sous-sa-mm50/29548.html) · ideal-investisseur.fr · Nov 17, 2026
  Valneva's stock dropped 15% in three months, trading at €2.55, and is testing its 20-day moving average ahead of its Q3 2026 results release on November 24.

[See all 20 articles](https://www.tamtam.ai/c/valneva/news)

## Valneva at a glance

Valneva is a B2B/B2G company in the Biotechnology Research industry, headquartered in Saint-Herblain, Pays de la Loire, France.

Valneva was founded in 2013.

Valneva has 251–1,000 employees.

Valneva's revenue is €175M (FY2025, publicly reported).

Valneva's SIREN number is 422497560.

## Frequently asked questions about Valneva

### What is Valneva's revenue?

Valneva's revenue is €175M (FY2025, publicly reported).

### How many employees does Valneva have?

Valneva has 251–1,000 employees.

### Where is Valneva headquartered?

Valneva is headquartered in Saint-Herblain, Pays de la Loire, France.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/valneva
